Clinical Trial Update: Short-Term Dual Antiplatelet and Maintenance CloPidogrel Therapy After Drug-Eluting Stent Implantation [Phase 4]

View source ↗

Summary

This update reports the termination of a Phase 4 trial evaluating short-term dual antiplatelet therapy with clopidogrel after drug-eluting stent implantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: CHEOL WHAN LEE, M.D., Ph.D | Conditions: Coronary Artery Disease | Phase 4 | Status: TERMINATED